Africa Malaria Diagnosis & Treatment Market Information, by Diagnosis (Rapid Diagnostic Tests (RDT’s), Molecular diagnostics, Microscopy), by Malarial Parasite (Plasmodium Falciparum, Plasmodium Vivax, Plasmodium Malariae and Plasmodium Ovale) - Forecast till 2023
Pune, India -- (SBWIRE) -- 07/17/2017 -- Market Highlights
Malaria is a deadly parasitic disease caused by plasmodium species which is transmitted by female anopheles mosquitos. P. falciparum accounts for almost 75% of the occurrence because other types of plasmodium generally cause a milder form of malaria. P. vivax accounts for 20% of the cases with the remaining 5% shared by P. ovale, and P. malariae. According to World Health Organization (WHO), the global incidence of malaria between 2010 and 2015, fell by 21% and the malaria mortality fell by 29%. However the African region carries a disproportionately high share of the global malaria burden and accounted for 90% of malaria cases and 92% of malaria deaths worldwide and sub-Saharan Africa accounted for 76% of malaria cases and 75% deaths globally. The global malaria diagnosis & treatment market is rising due to huge unmet medical needs in Africa and the huge growth in international anti-malarial funding. The other market drivers is the development of high sensitivity diagnostic kits with the ability to detect multiple types of malaria.
Africa Malaria Diagnosis & Treatment Market:
The Africa malaria diagnosis & treatment market has been evaluated as a growing market and it is expected that the market will touch high growth figures in future. The Africa malaria diagnosis market is expected to grow with a CAGR of ~28.0% during the forecast period while the Africa malaria treatment market is expected to grow with CAGR of ~8.1%.
Request a Sample Report@ https://www.marketresearchfuture.com/sample_request/2952
Key Players for Africa Malaria Diagnosis & Treatment Market:
- Alere Inc.,
- Access Bio Inc.,
- Premier Medical Corporation,
- Beckman Coulter/Danaher,
- Novartis Diagnostics,
- Siemens Healthcare,
- Bio-Rad Laboratories,
- Cipla Inc.,
- Ipca Laboratories Ltd.,
- Uni-Med India,
- Pfizer Inc.,
- Sun Pharmaceutical Industries Ltd.,
- Sanofi among others.
"Ask for your specific company profile and country level customization on reports"
The market restraints is the low per capita income and low healthcare penetration in Africa, corruption and civil wars in many sub Saharan nations of Africa etc. Development of drug resistance is the greatest market threat to treatment market. The latest detection of Artemisin resistant malaria is a cause of serious concern.
The domestic manufacturing in Africa is extremely poor especially with diagnostic kits. The drug manufacturing is better but still very dependent on imports especially from developing nations like India. Thus Africa has all the elements for being the largest malarial market except the poor economic and political conditions.
New drug development is a very effective strategy for being the market leader. However the strong resistant mechanism of malaria renders any new drug less effective. The product development include combination therapy to avoid the pitfalls of drug resistance and to reduce the side effects of first generation drugs.
Taste the market data and market information presented through more than 50 market data tables and figures spread in 110 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on "Africa Malaria Diagnosis & Treatment Market Research Report - Forecast to 2023"
Browse full report @ https://www.marketresearchfuture.com/reports/malaria-diagnosis-treatment-market-2952
The Hottest Trend in the Market
Malaria is a life threatening disease caused by the plasmodium protozoan transmitted by the female anopheles mosquito. The incidence and prevalence of malaria has been declining all over the world with African region being the only anomaly. According to World Health Organization (WHO), the global incidence of malaria between 2010 and 2015, fell by 21% and the malaria mortality by 29%. However the African region carries a disproportionately high share of the global malaria burden and accounted for 90% of malaria cases and 92% of malaria deaths worldwide and sub-Saharan Africa accounted for 76% of malaria cases and 75% deaths globally.
Thus, huge unmet needs is the prime market driver. Moreover the international funding for malaria has increased substantially which is a strong market driver. Other drivers include the hot and humid climatic conditions which support mosquito breeding, presence of low immunity population groups at higher risk of contracting malaria such as infants, children under 5 years of age, patients with low immunity such as those with HIV/AIDS etc.
The market restraints are the low per capita income in Africa, low penetration of healthcare, lack of sanitation etc. the market is also bifurcated in contractual and free market with governmental bodies and health organizations accounting for a sizable number of purchases.
Table of Content
1.2 Scope Of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure:
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Magarpatta Road, Hadapsar,
Pune - 411028
+1 646 845 9312